What does MEDITHERA do?

MEDITHERA is a pharmacy in Rixensart. Public Limited, started on 30 June 1986, 1 establishment.

What is the address of MEDITHERA?

The registered office of MEDITHERA is located at Avenue de Merode 36, 1330 Rixensart.

Is MEDITHERA still active?

Yes. According to the CBE (30 October 2026) MEDITHERA is active, legal situation “Normale toestand”, started on 30 June 1986.

Is MEDITHERA registered on Peppol?

Yes, MEDITHERA is registered on the Peppol network with ID 0208:0429134433.

What is the enterprise number of MEDITHERA?

The enterprise number of MEDITHERA is BE0429134433.

When was MEDITHERA founded?

MEDITHERA was founded on 30 June 1986.

Who are the directors of MEDITHERA?

According to the 2025 annual accounts, the directors of MEDITHERA are: MARC SEUTIN, PATRICIA BONABOT.

Is MEDITHERA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 30 June 1986; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did MEDITHERA make in 2025?

MEDITHERA posted a profit after taxes of € 11,471 in financial year 2025.

What is the revenue of MEDITHERA?

As a small company, MEDITHERA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 375,156.

How much does an employee at MEDITHERA earn?

The average wage cost per full-time employee at MEDITHERA was € 53,500 in 2025: staff costs of € 288,835 for 5.4 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does MEDITHERA have?

According to the 2025 annual accounts, MEDITHERA has 5.4 full-time equivalents (FTE).

MEDITHERA (Public Limited) - Rixensart - BE0429134433

Dossier MEDITHERA, printed on 30 October 2026 from databakkes.be/en/0429134433/medithera. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 49 % of short-term debt in 2025; threshold 65 %.
Shrinking team NBB

FTE fell two years in a row, from 6.4 to 5.4.

Financials

Financial year 2025

MEDITHERA from Rixensart, company number BE0429134433, closed financial year 2025 with a result of € 11,471 after tax. For that financial year MEDITHERA recorded a gross margin of € 375,156 and equity of € 399,044. Compared with financial year 2024, the result moved from € -82,311 to € 11,471. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2026.

What it is worth Growing

€ 399,044

▲ 3% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 11,471

▲ still € 82,311 loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 28,460

▲ € 25,749 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 337,044.

People and assets in 2025

Full-time equivalents

5.4

▼ 0.9 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 288,835

▼ 5% vs 2024

€ 53,500 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 14,129

▲ 27% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 9 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 285,408

▼ 10% vs 2024

€ 33,330 is repaid this year. At this pace the long-term loan is gone in ≈ 9 years.

Owed to suppliers

€ 19,228

▼ 62% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 36,214

▲ 6% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 467,318 Gross margin 2022: € 467,318 First fiscal year in the series	€ 418,701 Gross margin 2023: € 418,701 ▼ 10% vs 2022 (€ 467,318) Unfavourable step	€ 301,454 Gross margin 2024: € 301,454 ▼ 28% vs 2023 (€ 418,701) Unfavourable step	€ 375,156 Gross margin 2025: € 375,156 ▲ 24% vs 2024 (€ 301,454) Favourable step	▲ 24%
Profit after taxes	€ 55,403 Profit after taxes 2022: € 55,403 First fiscal year in the series	€ 11,912 Profit after taxes 2023: € 11,912 ▼ 78% vs 2022 (€ 55,403) Unfavourable step	€ -82,311 Profit after taxes 2024: € -82,311 ▼ € 94,223 vs 2023 (€ 11,912) Unfavourable step	€ 11,471 Profit after taxes 2025: € 11,471 ▲ € 93,782 vs 2024 (€ -82,311) Favourable step	▲ € 93,782
Equity	€ 474,269 Equity 2022: € 474,269 First fiscal year in the series	€ 469,884 Equity 2023: € 469,884 ▼ 1% vs 2022 (€ 474,269) Unfavourable step	€ 387,573 Equity 2024: € 387,573 ▼ 18% vs 2023 (€ 469,884) Unfavourable step	€ 399,044 Equity 2025: € 399,044 ▲ 3% vs 2024 (€ 387,573) Favourable step	▲ 3%
Total debts	€ 127,825 Total debts 2022: € 127,825 First fiscal year in the series	€ 673,232 Total debts 2023: € 673,232 ▲ € 545,407 vs 2022 (€ 127,825) Unfavourable step	€ 633,897 Total debts 2024: € 633,897 ▼ 6% vs 2023 (€ 673,232) Favourable step	€ 572,968 Total debts 2025: € 572,968 ▼ 10% vs 2024 (€ 633,897) Favourable step	▼ 10%
Cash	€ 125,916 Cash 2022: € 125,916 First fiscal year in the series	€ 62,511 Cash 2023: € 62,511 ▼ 50% vs 2022 (€ 125,916) Unfavourable step	€ 2,711 Cash 2024: € 2,711 ▼ 96% vs 2023 (€ 62,511) Unfavourable step	€ 28,460 Cash 2025: € 28,460 ▲ € 25,749 vs 2024 (€ 2,711) Favourable step	▲ € 25,749
Land & buildings	€ 62,116 Land & buildings 2022: € 62,116 First fiscal year in the series	€ 305,515 Land & buildings 2023: € 305,515 ▲ € 243,399 vs 2022 (€ 62,116) Unchanged	€ 293,345 Land & buildings 2024: € 293,345 ▼ 4% vs 2023 (€ 305,515) Unchanged	€ 310,296 Land & buildings 2025: € 310,296 ▲ 6% vs 2024 (€ 293,345) Unchanged	▲ 6%
Retained profit	€ 412,269 Retained profit 2022: € 412,269 First fiscal year in the series	€ 407,884 Retained profit 2023: € 407,884 ▼ 1% vs 2022 (€ 412,269) Unfavourable step	€ 325,573 Retained profit 2024: € 325,573 ▼ 20% vs 2023 (€ 407,884) Unfavourable step	€ 337,044 Retained profit 2025: € 337,044 ▲ 4% vs 2024 (€ 325,573) Favourable step	▲ 4%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 16,297 Dividend 2023: € 16,297 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 16,297) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 28,857 Bank debt 2022: € 28,857 First fiscal year in the series	€ 358,990 Bank debt 2023: € 358,990 ▲ € 330,133 vs 2022 (€ 28,857) Unfavourable step	€ 318,184 Bank debt 2024: € 318,184 ▼ 11% vs 2023 (€ 358,990) Favourable step	€ 285,408 Bank debt 2025: € 285,408 ▼ 10% vs 2024 (€ 318,184) Favourable step	▼ 10%
Balance sheet total	€ 602,094 Balance sheet total 2022: € 602,094 First fiscal year in the series	€ 1,143,116 Balance sheet total 2023: € 1,143,116 ▲ 90% vs 2022 (€ 602,094) Unchanged	€ 1,021,471 Balance sheet total 2024: € 1,021,471 ▼ 11% vs 2023 (€ 1,143,116) Unchanged	€ 972,011 Balance sheet total 2025: € 972,011 ▼ 5% vs 2024 (€ 1,021,471) Unchanged	▼ 5%
Employees (FTE)	6.5 Employees (FTE) 2022: 6.5 First fiscal year in the series	6.4 Employees (FTE) 2023: 6.4 ▼ 0.1 vs 2022 (6.5) Unchanged	6.3 Employees (FTE) 2024: 6.3 ▼ 0.1 vs 2023 (6.4) Unchanged	5.4 Employees (FTE) 2025: 5.4 ▼ 0.9 vs 2024 (6.3) Unchanged	▼ 0.9

Key figures of MEDITHERA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MEDITHERA?

What happened at MEDITHERA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 31, 2026 New annual accounts for financial year 2025: profit of € 11,471. Source: NBB ↗
Jun 28, 1988 New establishment in Rixensart. KBO
Jun 30, 1986 Start of the company according to the CBE. KBO

In short

From € 55,403 profit in 2022 to € 11,471 profit in 2025.

Paid € 29,027 in corporate taxes since 2022.

Best year ever: 2022, with € 55,403 profit.

On average € 69,500 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

MARC SEUTIN

PATRICIA BONABOT

MEDITHERA

DEFRANCE PHARMACIE 100%

Behind MEDITHERA are MARC SEUTIN and PATRICIA BONABOT. It owns 100% of DEFRANCE PHARMACIE itself.

Directors

According to the 2025 annual accounts

MARC SEUTIN

Director

PATRICIA BONABOT

Managing director

Establishments

Establishment units

Physical locations of this company

Registered office

Avenue de Merode 36

1330 Rixensart

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0429.134.433

VAT number

BE 0429.134.433

Registered office

Avenue de Merode 36, 1330 Rixensart

Names & denominations

MEDITHERA

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

30 June 1986

Peppol

Active · Active since 7 Nov 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

MEDITHERA

Warning lights

Financials

What happened to MEDITHERA?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions